Growth Metrics

RxSight (RXST) Net Cash Flow (2020 - 2026)

RxSight filings provide 6 years of Net Cash Flow readings, the most recent being -$9.7 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 26952.78% to -$9.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 54.11% decrease, with the full-year FY2025 number at $3.2 million, down 54.11% from a year prior.
  • Net Cash Flow hit -$9.7 million in Q4 2025 for RxSight, up from -$10.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $29.6 million in Q2 2022 to a low of -$43.7 million in Q4 2021.
  • Median Net Cash Flow over the past 5 years was -$68500.0 (2023), compared with a mean of $313200.0.
  • Biggest five-year swings in Net Cash Flow: surged 5507.54% in 2021 and later plummeted 26952.78% in 2025.
  • RxSight's Net Cash Flow stood at -$43.7 million in 2021, then skyrocketed by 106.55% to $2.9 million in 2022, then tumbled by 106.05% to -$173000.0 in 2023, then skyrocketed by 120.81% to $36000.0 in 2024, then plummeted by 26952.78% to -$9.7 million in 2025.
  • The last three reported values for Net Cash Flow were -$9.7 million (Q4 2025), -$10.7 million (Q3 2025), and $12.3 million (Q2 2025) per Business Quant data.